Neurological Biomarkers Market Size to Grow by USD 6.00 billion, Increasing Incidences of Neurological Disorders to Drive Growth - Technavio

NEW YORK, Aug. 30, 2022 /PRNewswire/ -- The neurological biomarkers market will be driven by factors such as the increasing incidences of neurological disorders. Patients with severe neurological disorders such as epilepsy, Parkinson's disease, stroke, and brain tumors, are at a high risk of disability. These disorders can also be fatal. They can occur due to factors such as bacterial and viral infections, genetic factors, and the lack of immune response. Parkinson's disease is one of the most common types of neurological diseases. The prevalence of the disease is more common among the geriatric population. According to The World Bank Group, the percentage of the population aged 65 and above in the US increased from 14.26% in 2014 to 16.20% in 2020. Therefore, factors such as the increasing prevalence of various neurological disorders and the growing demand for the treatment of such disorders will contribute to the growth of the global neurological biomarkers during the forecast period.

The neurological biomarkers market size is expected to grow by USD 6.00 bn from 2021 to 2026. Moreover, the growth momentum of the market will accelerate at a CAGR of 12.43% during the forecast period.

Get a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format

The increasing focus on accurate neurological diagnostics is a trend in the market. CT scans can be used to check bleeding or swelling in the brain, but they may not be accurate in some cases. As a result, many brain injuries are unrecognized and undiagnosed. Therefore, in recent years, there has been a trend of blood tests for detecting neurological biomarkers. Vendors are starting clinical trials and R&D of biomarkers, which can give accurate results for neurological disorders. Such developments will contribute to the neurological biomarkers market growth during the forecast period.

Stay updated with the latest trends in the neurological biomarkers market. Request a Free PDF Sample

This market has been segmented by indication (AD, PD, ASD, MS, and Others), end-user (hospitals, clinical diagnostic centers, research organizations, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)).

North America will lead the neurological biomarkers market during the forecast period. This growth is driven by factors such as the increasing demand for the diagnosis of neurological disorders. However, market growth in this region will be slower than the growth of the market in other regions. The US and Canada are the key countries for the neurological biomarkers market in North America.

The AD segment will be the largest revenue-generating indication segment during the forecast period. AD is a brain disorder that can destroy memory, thinking skills, and the ability to carry out simple tasks. Neurobiological biomarkers can be used for the early detection of AD. They indicate progressive development before the main manifestations of the disease. Such factors will fuel the neurological biomarkers market growth during the forecast period.

This report provides a full list of key vendors, their strategies, and latest developments. Request a FREE PDF Sample Now

Human Organoids Market by End-user and Geography - Forecast and Analysis 2022-2026

Recombinant Proteins Market by Application and Geography - Forecast and Analysis 2022-2026

Browse Health Care Market Report

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Indication
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 13: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 18: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Indication

• 5.1 Market segments
• Exhibit 25: Chart on Indication - Market share 2021-2026 (%)
• Exhibit 26: Data Table on Indication - Market share 2021-2026 (%)

• 5.2 Comparison by Indication
• Exhibit 27: Chart on Comparison by Indication
• Exhibit 28: Data Table on Comparison by Indication

• 5.3 AD - Market size and forecast 2021-2026
• Exhibit 29: Chart on AD - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Data Table on AD - Market size and forecast 2021-2026 ($ million)
• Exhibit 31: Chart on AD - Year-over-year growth 2021-2026 (%)
• Exhibit 32: Data Table on AD - Year-over-year growth 2021-2026 (%)

• 5.4 PD - Market size and forecast 2021-2026
• Exhibit 33: Chart on PD - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Data Table on PD - Market size and forecast 2021-2026 ($ million)
• Exhibit 35: Chart on PD - Year-over-year growth 2021-2026 (%)
• Exhibit 36: Data Table on PD - Year-over-year growth 2021-2026 (%)

• 5.5 ASD - Market size and forecast 2021-2026
• Exhibit 37: Chart on ASD - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Data Table on ASD - Market size and forecast 2021-2026 ($ million)
• Exhibit 39: Chart on ASD - Year-over-year growth 2021-2026 (%)
• Exhibit 40: Data Table on ASD - Year-over-year growth 2021-2026 (%)

• 5.6 MS - Market size and forecast 2021-2026
• Exhibit 41: Chart on MS - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Data Table on MS - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Chart on MS - Year-over-year growth 2021-2026 (%)
• Exhibit 44: Data Table on MS - Year-over-year growth 2021-2026 (%)

• 5.7 Others - Market size and forecast 2021-2026
• Exhibit 45: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 46: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 48: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.8 Market opportunity by Indication
• Exhibit 49: Market opportunity by Indication ($ million)

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 50: Chart on End-user - Market share 2021-2026 (%)
• Exhibit 51: Data Table on End-user - Market share 2021-2026 (%)

• 6.2 Comparison by End-user
• Exhibit 52: Chart on Comparison by End-user
• Exhibit 53: Data Table on Comparison by End-user

• 6.3 Hospitals - Market size and forecast 2021-2026
• Exhibit 54: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)

• 6.4 Clinical diagnostic centers - Market size and forecast 2021-2026
• Exhibit 58: Chart on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Clinical diagnostic centers - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Clinical diagnostic centers - Year-over-year growth 2021-2026 (%)

• 6.5 Research organizations and others - Market size and forecast 2021-2026
• Exhibit 62: Chart on Research organizations and others - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Research organizations and others - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Research organizations and others - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Research organizations and others - Year-over-year growth 2021-2026 (%)

• 6.6 Market opportunity by End-user
• Exhibit 66: Market opportunity by End-user ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
• Exhibit 67: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
• Exhibit 68: Chart on Market share by geography 2021-2026 (%)
• Exhibit 69: Data Table on Market share by geography 2021-2026 (%)

• 8.2 Geographic comparison
• Exhibit 70: Chart on Geographic comparison
• Exhibit 71: Data Table on Geographic comparison

• 8.3 North America - Market size and forecast 2021-2026
• Exhibit 72: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 73: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 74: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 75: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 8.4 Europe - Market size and forecast 2021-2026
• Exhibit 76: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 77: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 78: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 79: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 8.5 Asia - Market size and forecast 2021-2026
• Exhibit 80: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 81: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 82: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 83: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 84: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 85: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 86: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 87: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 8.7 US - Market size and forecast 2021-2026
• Exhibit 88: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 89: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 90: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 91: Data Table on US - Year-over-year growth 2021-2026 (%)

• 8.8 Germany - Market size and forecast 2021-2026
• Exhibit 92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 94: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 95: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 8.9 UK - Market size and forecast 2021-2026
• Exhibit 96: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 97: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 98: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 99: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 8.10 Canada - Market size and forecast 2021-2026
• Exhibit 100: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 101: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 102: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 103: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 8.11 France - Market size and forecast 2021-2026
• Exhibit 104: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 105: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 106: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 107: Data Table on France - Year-over-year growth 2021-2026 (%)

• 8.12 Market opportunity by geography
• Exhibit 108: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2021 and 2026

• 9.4 Market trends

10 Vendor Landscape

• 10.1 Overview

• 10.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 10.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption

• 10.4 Industry risks
• Exhibit 112: Impact of key risks on business

11 Vendor Analysis

• 11.1 Vendors covered
• Exhibit 113: Vendors covered

• 11.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification

• 11.3 Bio Rad Laboratories Inc.
• Exhibit 115: Bio Rad Laboratories Inc. - Overview
• Exhibit 116: Bio Rad Laboratories Inc. - Business segments
• Exhibit 117: Bio Rad Laboratories Inc. - Key news
• Exhibit 118: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 119: Bio Rad Laboratories Inc. - Segment focus

• 11.4 bioMerieux SA
• Exhibit 120: bioMerieux SA - Overview
• Exhibit 121: bioMerieux SA - Business segments
• Exhibit 122: bioMerieux SA - Key offerings
• Exhibit 123: bioMerieux SA - Segment focus

• 11.5 Charles River Laboratories International Inc.
• Exhibit 124: Charles River Laboratories International Inc. - Overview
• Exhibit 125: Charles River Laboratories International Inc. - Business segments
• Exhibit 126: Charles River Laboratories International Inc. - Key news
• Exhibit 127: Charles River Laboratories International Inc. - Key offerings
• Exhibit 128: Charles River Laboratories International Inc. - Segment focus

• 11.6 F. Hoffmann La Roche Ltd.
• Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus

• 11.7 Merck KGaA
• Exhibit 134: Merck KGaA - Overview
• Exhibit 135: Merck KGaA - Business segments
• Exhibit 136: Merck KGaA - Key news
• Exhibit 137: Merck KGaA - Key offerings
• Exhibit 138: Merck KGaA - Segment focus

• 11.8 Myriad Genetics Inc.
• Exhibit 139: Myriad Genetics Inc. - Overview
• Exhibit 140: Myriad Genetics Inc. - Product / Service
• Exhibit 141: Myriad Genetics Inc. - Key offerings

• 11.9 Proteome Sciences plc
• Exhibit 142: Proteome Sciences plc - Overview
• Exhibit 143: Proteome Sciences plc - Product / Service
• Exhibit 144: Proteome Sciences plc - Key offerings

• 11.10 QIAGEN NV
• Exhibit 145: QIAGEN NV - Overview
• Exhibit 146: QIAGEN NV - Product / Service
• Exhibit 147: QIAGEN NV - Key news
• Exhibit 148: QIAGEN NV - Key offerings

• 11.11 Quanterix Corp.
• Exhibit 149: Quanterix Corp. - Overview
• Exhibit 150: Quanterix Corp. - Product / Service
• Exhibit 151: Quanterix Corp. - Key offerings

• 11.12 Thermo Fisher Scientific Inc.
• Exhibit 152: Thermo Fisher Scientific Inc. - Overview
• Exhibit 153: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 154: Thermo Fisher Scientific Inc. - Key news
• Exhibit 155: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 156: Thermo Fisher Scientific Inc. - Segment focus

12 Appendix

• 12.1 Scope of the report

• 12.2 Inclusions and exclusions checklist
• Exhibit 157: Inclusions checklist
• Exhibit 158: Exclusions checklist

• 12.3 Currency conversion rates for US$
• Exhibit 159: Currency conversion rates for US$

• 12.4 Research methodology
• Exhibit 160: Research methodology
• Exhibit 161: Validation techniques employed for market sizing
• Exhibit 162: Information sources

• 12.5 List of abbreviations
• Exhibit 163: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio